We are live on ! Find out more
MYOK

MyoKardia
MYOK

Delisted

MYOK was delisted on the 16th of November, 2020.

73 hedge funds and large institutions have $196M invested in MyoKardia in 2017 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 27 increasing their positions, 16 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

70% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 10

69% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 16

30% more capital inflows, than outflows

Capital inflows: $24.8M | Capital outflows: $19M

3% more funds holding

Funds holding: 71 → 73 (+2)

0.59% less ownership

Funds ownership: 47.92% → 47.33% (-0.59%)

Holders
73
Holders Change
+2
Holders Change %
+2.82%
% of All Funds
1.81%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
17
Increased
27
Reduced
16
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

MYOK Hedge Fund Activity: Q1 2017 in Review

73 of the 4,036 institutional investors tracked by Wall St. Rank reported a position in MyoKardia (MYOK) for Q1 2017, worth a combined $196M — up 0.26% from $195M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new MYOK positions and 10 closed out — a net gain of 7 holders — while 27 added to existing stakes and 16 trimmed.

The largest buyer was BlackRock, adding an estimated $8.29M. The largest seller was Fidelity Investments, cutting an estimated $7.97M.

  • 73 institutional investors held MyoKardia (MYOK) as of Q1 2017, up from 71 in Q4 2016.
  • Funds reported $196M of MyoKardia stock for Q1 2017, up 0.26% quarter-over-quarter.
  • 17 funds opened new MyoKardia positions in Q1 2017 and 10 closed out, a net change of +7 holders.
  • The largest MyoKardia buyer in Q1 2017 was BlackRock, an estimated $8.29M added.
  • The largest MyoKardia seller in Q1 2017 was Fidelity Investments, an estimated $7.97M sold.

Based on aggregated 13F filings for Q1 2017.